High Content, Multi-Parameter Analyses in Buccal Cells to Identify Alzheimer's Disease.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Current Alzheimer Research

• Publication date

  2016-06-30

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2174/1567205013666160315112151PMID 26975368
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Plasma phospholipids identify antecedent memory impairment in older adults

  2014cited by this paper
• Biomarkers of Alzheimer’s Disease Risk in Peripheral Tissues; Focus on Buccal Cells

  2014cited by this paper
• Changes in plasma amyloid beta in a longitudinal study of aging and Alzheimer's disease

  2014cited by this paper
• Altered cytological parameters in buccal cells from individuals with mild cognitive impairment and Alzheimer's disease

  2014cited by this paper
• Three-Dimensional Quantitative Imaging of Telomeres in Buccal Cells Identifies Mild, Moderate, and Severe Alzheimer's Disease Patients

  2014cited by this paper
• Ammonium hydroxide treatment of Aβ produces an aggregate free solution suitable for biophysical and cell culture characterization

  2013cited by this paper
• 2013 Alzheimer's disease facts and figures

  2013cited by this paper
• The global prevalence of dementia: A systematic review and metaanalysis

  2013cited by this paper
• Blood-based protein biomarkers for diagnosis of Alzheimer disease.

  2012cited by this paper
• Changes in neuronal DNA content variation in the human brain during aging

  2012cited by this paper
• Automation of the buccal micronucleus cytome assay using laser scanning cytometry.

  2011cited by this paper
• Homocysteine, Vitamin B12, and Folic Acid Levels in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: Baseline Characteristics in Subjects of the Australian Imaging Biomarker Lifestyle Study

  2011cited by this paper
• Human Platelets Tau: A Potential Peripheral Marker for Alzheimer's Disease

  2011cited by this paper
• Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease.

  2011cited by this paper
• Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease

  2011cited by this paper
• Association of micronucleus frequency with neurodegenerative diseases.

  2011cited by this paper
• P3‐211: Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease

  2010cited by this paper
• Olfactory epithelium amyloid‐β and paired helical filament‐tau pathology in Alzheimer disease

  2010cited by this paper
• Cerebrospinal Fluid Biomarkers for Alzheimer's Disease

  2009cited by this paper
• Altered Cholesterol Ester Cycle in Skin Fibroblasts from Patients with Alzheimer's Disease

  2009cited by this paper
• Buccal micronucleus cytome assay

  2009cited by this paper
• Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease

  2009cited by this paper
• Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease

  2009cited by this paper
• The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease

  2009cited by this paper
• Tau pathophysiology in neurodegeneration: a tangled issue.

  2009cited by this paper
• Telomere length in white blood cells, buccal cells and brain tissue and its variation with ageing and Alzheimer's disease.

  2008cited by this paper
• Peripheral Aβ subspecies as risk biomarkers of Alzheimer's disease

  2008cited by this paper
• The Worldwide Challenge of the Dementias: A Role for B Vitamins and Homocysteine?

  2008cited by this paper
• Cytologic and cytometric analysis of oral mucosa in Alzheimer's disease.

  2008cited by this paper
• The repressive effect of green tea ingredients on amyloid precursor protein (APP) expression in oral carcinoma cells in vitro and in vivo.

  2007cited by this paper
• Buccal micronucleus cytome biomarkers may be associated with Alzheimer's disease.

  2007cited by this paper
• Neuroglobin attenuates β-amyloid neurotoxicity in vitro and transgenic Alzheimer phenotype in vivo

  2007cited by this paper
• Aneuploidy and DNA Replication in the Normal Human Brain and Alzheimer's Disease

  2007cited by this paper
• Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease.

  2007cited by this paper
• Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease.

  2005cited by this paper
• Global prevalence of dementia: a Delphi consensus study

  2005cited by this paper
• Next-generation laser scanning cytometry.

  2004cited by this paper
• Alzheimer's disease: the cholesterol connection

  2003cited by this paper
• The τ Protein of Oral Epithelium Increases in Alzheimer's Disease

  2002cited by this paper
• Alzheimer's disease

  2002cited by this paper
• The public health impact of Alzheimer's disease, 2000-2050: potential implication of treatment advances.

  2002cited by this paper
• The tau protein of oral epithelium increases in Alzheimer's disease.

  2002cited by this paper
• Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry

  2001cited by this paper
• The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.

  2001cited by this paper
• Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid ß-protein

  2001cited by this paper
• Lipid Composition in Different Regions of the Brain in Alzheimer's Disease/Senile Dementia of Alzheimer's Type

  1992cited by this paper
• Amyloid protein and Alzheimer's disease.

  1991cited by this paper
• Lipid Compositions of Different Regions of the Human Brain During Aging

  1990cited by this paper
• Changes in accessibility of DNA to various fluorochromes during spermatogenesis.

  1986cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• Accessibility of DNA in situ to various fluorochromes: relationship to chromatin changes during erythroid differentiation of Friend leukemia cells.

  1984cited by this paper
• Acetic acid treatment denatures DNA while preserving chromosomal morphology during the in situ hybridization procedure.

  1978cited by this paper
• Cell cycle-related changes in nuclear chromatin of stimulated lymphocytes as measured by flow cytometry.

  1977cited by this paper

• Skin-brain axis in Alzheimer's disease - Pathologic, diagnostic, and therapeutic implications: A Hypothetical Review

  2024cites this paper
• Saliva Proteome, Metabolome and Microbiome Signatures for Detection of Alzheimer’s Disease

  2024cites this paper
• Exploring the Association between Pro-Inflammation and the Early Diagnosis of Alzheimer’s Disease in Buccal Cells Using Immunocytochemistry and Machine Learning Techniques

  2024cites this paper
• The use of ATR-FTIR spectroscopy for the diagnosis of Alzheimer’s disease using oral buccal cells

  2023cites this paper
• miR-29c-3p Attenuates β-Amyloid-Induced Neurotoxicity in Alzheimer’s Disease Through Regulating β-Site Amyloid Precursor Protein-Cleaving Enzyme 1

  2023cites this paper
• miR-29c-3p Attenuates beta-Amyloid-Induced Neurotoxicity in Alzheimer's Disease Through Regulating beta-Site Amyloid Precursor Protein-Cleaving Enzyme 1.

  2023cites this paper
• Aβ42 as a Biomarker of Alzheimer’s Disease: Is Saliva a Viable Alternative to Cerebrospinal Fluid?

  2022cites this paper
• Oral Mucosa Derived α−Synuclein as a Potential Diagnostic Biomarker for Parkinson′s Disease

  2022cites this paper
• Diagnostic possibilities of studying the buccal epithelium in the elderly with cognitive impairments

  2022cites this paper
• Diagnose it yourself: will there be a home test kit for Alzheimer's disease?

  2021cites this paper
• Micronuclei, inflammation and auto-immune disease.

  2020cites this paper
• Optimization of an oral mucosa in vitro model based on cell line TR146

  2020cites this paper
• Biomarkers as a Different Approach in Prevention and Treatment of Drug Addiction (Preliminary Study).

  2020cites this paper
• Buccal Mucosa Biomarkers in Alzheimer's Disease.

  2020cites this paper
• Diagnostic Biomarkers for Alzheimer’s Disease Using Non-Invasive Specimens

  2020cites this paper
• Characterization of 5-methylcytosine and 5-hydroxymethylcytosine in human placenta cell types across gestation

  2019cites this paper
• Salivary Biomarkers for Alzheimer’s Disease and Related Disorders

  2019cites this paper
• Expression of Aβ42, τ-Protein, p16, p53 in Buccal Epithelium: Prospects for Use in the Diagnostics of Alzheimer’s Disease and Rate of Aging

  2019cites this paper
• Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

  2018cites this paper
• Current State of Saliva Biomarkers for Aging and Alzheimer's Disease.

  2018cites this paper
• Super‐resolution structure of DNA significantly differs in buccal cells of controls and Alzheimer's patients

  2017cites this paper
• MicroRNA-125b promotes neurons cell apoptosis and Tau phosphorylation in Alzheimer's disease.

  2017cites this paper
• Vitamins Associated with Brain Aging, Mild Cognitive Impairment, and Alzheimer Disease: Biomarkers, Epidemiological and Experimental Evidence, Plausible Mechanisms, and Knowledge Gaps.

  2017cites this paper
• Tau Protein in Oral Mucosa and Cognitive State: A Cross-sectional Study

  2017cites this paper